Life Scientist > Biotechnology

Living skin with blood vessels can now be 3D printed

13 November, 2019

The work serves as a significant step towards creating grafts that are more like the skin our bodies produce naturally.


Drug accelerates cell division in aggressive breast cancers

08 November, 2019

A new drug blocks one of cancer's key evolutionary escape routes from chemotherapy, reinvigorating the response to chemotherapy in cancers that have become resistant.


Drug development process — from the start

08 November, 2019

According to Fredrik Sundberg, PhD, global director of strategic customer relations at GE Healthcare, the key to successfully launching a drug product on the market is to thoroughly understand the drug development process.


Partnership to develop drugs for eye disease

07 November, 2019

PYC Therapeutics has entered into a commercial collaboration with Lions Eye Institute to develop drugs for a leading cause of blinding eye disease.


Nanoparticles could transport anticancer agent to cells

30 October, 2019

Metal–organic frameworks (MOFs) could present a viable platform for delivering a potent anticancer agent to cells.


Threefold approach to improving anticancer drug

24 October, 2019

Biomedical engineers brought together tools from genome engineering, protein engineering and biomaterials science to improve the efficacy, accuracy and longevity of certain cancer therapies.


Light-activated catalyst destroys cancer cells' energy source

11 October, 2019

Scientists have developed a compound of the metal iridium that will kill cancer cells in culture even when oxygen concentration is low.


Thermostable vaccine can be stored at warm temperatures

10 October, 2019

The vaccine candidate has been engineered using a synthetic protein scaffold that could revolutionise the way vaccines are designed, produced and stored.


Psoriasis drug could treat rare bone cancer

26 September, 2019

Researchers have discovered that the inflammatory molecule IL23, investigated for a number of autoimmune diseases, is critical to osteosarcoma formation and progression.


Arthritis drug provides relief for blood cancer patients

20 September, 2019

A simple arthritis drug could be an effective, low-cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET).


Aus bioscience company acquires anticancer drug platform

19 September, 2019

The iQ Group Global has announced its acquisition of a novel anticancer drug platform, known as TEX Core, from the University of Texas.


CELLINK BIO X6 bioprinting platform

10 September, 2019

CELLINK has announced the BIO X6 — a six-printhead bioprinting platform that enables users to combine several materials, cells and tools.


Drug transporters bring cancer medication to its destination

02 September, 2019

Researchers have transformed proteins and antibodies into stable, highly functional drug transporters with which tumour cells can be detected and killed.


Neural implant controlled by a smartphone

23 August, 2019

Using Lego-like replaceable drug cartridges and Bluetooth Low Energy, the device can target specific neurons of interest using drugs and light for prolonged periods.


SA set to lift ban on GM crops

22 August, 2019

Farmers on mainland South Australia will be given the choice to plant genetically modified (GM) food crops next season.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd